SPL 2.04% 9.6¢ starpharma holdings limited

We often have posts that research claims for Viraleze are not...

  1. 1,004 Posts.
    lightbulb Created with Sketch. 185
    We often have posts that research claims for Viraleze are not valid because Starpharma didn't arrange independant, large enough trials, and they lacked medical journal articles and the PEER REVIEW.

    Seems in 2020 both The Lancet and New England Journal were caught out by fake peer reviews on two covid treatments which even claimed large FAKE worldwide data sets even including imaginary Australian Hospitals data and the means to check this info and its supposed de identification of included participants was all a con.

    https://www.theguardian.com/world/2020/jun/03/covid-19-surgisphere-who-world-health-organization-hydroxychloroquine
    most important factor was they they lacked "peer review"

    Maybe the reported evidence for Viraleze efficacy reported at conferences, by Schripp Institute and the UK NHS Hosp Ashford St Peters study should inform TGA about the covid viral load reductions without waiting for Peer Review.


 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.6¢
Change
-0.002(2.04%)
Mkt cap ! $40.06M
Open High Low Value Volume
9.6¢ 9.6¢ 9.6¢ $279 2.903K

Buyers (Bids)

No. Vol. Price($)
3 65644 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 34876 2
View Market Depth
Last trade - 11.41am 08/10/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.